Light therapy may tame rejection in kidney transplants

NCT ID NCT04870437

Recruiting now Knowledge-focused Sponsor: University Hospital, Angers Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 23 times

Summary

This study tests whether a treatment called extracorporeal phototherapy (ECP) can help control chronic antibody-mediated rejection, a major cause of kidney transplant failure. ECP involves taking a patient's blood cells, exposing them to UV light, and returning them to the body to calm the immune system. Researchers will study 30 kidney transplant patients to see if ECP can reduce harmful immune cells and improve transplant survival.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

CHU Clermont Ferrand
RECRUITING

Clermont-Ferrand, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
CHU de STRASBOURG
RECRUITING

Strasbourg, France

Contact Email: •••••@•••••
Chu Besancon
RECRUITING

Besançon, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Chu Saint Etienne
RECRUITING

Saint-Etienne, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

KIDNEY TRANSPLANTATION KIDNEY TRANSPLANTATION